[1] SIEGEL R L,MILLER K D,JEMAl A.Cancer statistics,2019[J].CA Cancer J Clin,2019,69(1):7-34.
[2] McGUIGAN A,KELLY P,TURKINGTON R C,et al.Pancreatic cancer:a review of clinical diagnosis,epidemiology,treatment and outcomes[J].World J Gastroenterol,2018,24(43):4846-4861.
[3] COPPÉ J P,PATIL C K,RODIER F,et al.Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor[J].PLoS Biol,2008,6(12):2853-2868.
[4] DAVALOS A R,COPPE J P,CAMPISI J,et al.Senescent cells as a source of inflammatory factors for tumor progression[J].Cancer Metastasis Rev,2010,29(2):273-283.
[5] FAGET D V,REN Q,STEWART S A.Unmasking senescence:context-dependent effects of SASP in cancer[J].Nat Rev Cancer,2019,19(8):439-453.
[6] KUILMAN T,MICHALOGLOU C,VREDEVELD L C,et al.Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network[J].Cell,2008,133(6):1019-1031.
[7] ORTIZ-MONTERO P,LONDOÑO-VALLEJO A,VERNOT J P.Senescence-associated IL-6 and IL-8 cytokines induce a self-and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line[J].Cell Commun Signal,2017,15(1):17-24.
[8] LAU L,PORCIUNCULA A,YU A,et al.Uncoupling the senescence-associated secretory phenotype from cell cycle exit via interleukin-1 inactivation unveils its protumorigenic role[J].Mol Cell Biol,2019,39(12):16-18.
[9] STORZ P.KRas,ROS and the initiation of pancreatic cancer[J].Small GTPases,2017,8(1):38-42.
[10] NAGAI E,UEKI T,CHIJIIWA K,et al.Intraductal papillary mucinous neoplasms of the pancreas associated with so-called "mucinous ductal ectasia".Histochemical and immunohistochemical analysis of 29 cases[J].Am J Surg Pathol,1995,19(5):576-589.
[11] MIYASAKA Y,NAGAI E,OHUCHIDA K,et al.Senescence in intraductal papillary mucinous neoplasm of the pancreas[J].Hum Pathol,2011,42(12):2010-2017.
[12] DE LA O J P,EMERSON L L,GOODMAN J L,et al.Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia[J].Proc Natl Acad Sci U S A,2008,105(48):18907-18912.
[13] CALDWELL M E,DENICOLA G M,MARTINS C P,et al.Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer[J].Oncogene,2012,31(12):1599-1608.
[14] MORTON J P,TIMPSON P,KARIM S A,et al.Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer[J].Proc Natl Acad Sci U S A,2010,107(1):246-251.
[15] MORTON J P,JAMIESON N B,KARIM S A,et al.LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest[J].Gastroenterology,2010,139(2):586-597.
[16] SONG Y,BABA T,MUKAIDA N.Gemcitabine induces cell senescence in human pancreatic cancer cell lines[J].Biochem Biophys Res Commun,2016,477(3):515-519.
[17] GRANDINETTI K B,DAVID G.Sin3B:an essential regulator of chromatin modifications at E2F target promoters during cell cycle withdrawal[J].Cell Cycle,2008,7(11):1550-1554.
[18] RIELLAND M,CANTOR D J,GRAVELINE R,et al.Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression[J].J Clin Invest,2014,124(5):2125-2135.
[19] ZHU Y,HERNDON J M,SOJKA D K,et al.Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression[J].Immunity,2017,47(2):323-338.
[20] SUMTER T F,XIAN L,HUSO T,et al.The high mobility group A1(HMGA1) transcriptome in cancer and development[J].Curr Mol Med,2016,16(4):353-393.
[21] NACARELLI T,LAU L,FUKUMOTO T,et al.NAD+metabolism governs the proinflammatory senescence-associated secretome[J].Nat Cell Biol,2019,21(3):397-407.
[22] ERKAN M,ADLER G,APTE M V,et al.StellaTUM:current consensus and discussion on pancreatic stellate cell research[J].Gut,2012,61(2):172-178.
[23] FITZNER B,LANGE A,MVLLER S,et al.Cdkn1a is a key mediator of rat pancreatic stellate cell senescence[J].Pancreatology,2013,13(3):254-262.
[24] SHAO C,TU C,CHENG X,et al.Inflammatory and senescent phenotype of pancreatic stellate cells induced by sqstm1 downregulation facilitates pancreatic cancer progression[J].Int J Biol Sci,2019,15(5):1020-1029.
[25] CHARRIER A,CHEN R,KEMPER S,et al.Regulation of pancreatic inflammation by connective tissue growth factor (CTGF/CCN2)[J].Immunology,2014,141(4):564-576.
[26] HAQUE I,MEHTA S,MAJUMDER M,et al.Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis[J].Mol Cancer,2011,10(8):1476-4598.
[27] JUN J I,LAU L F.The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing[J].Nat Cell Biol,2010,12(7):676-685.
[28] YAMAO T,YAMASHITA YI,YAMAMURA K,et al.Cellular senescence,represented by expression of caveolin-1,in cancer-associated fibroblasts promotes tumor invasion in pancreatic cancer[J].Ann Surg Oncol,2019,26(5):1552-1559.
[29] RUSCETTI M,MORRIS J P 4th,MEZZADRA R,et al.Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer[J].Cell,2020,181(2):424-441.
[30] YANG S,HWANG S,KIM M,et al.Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibition[J].Cell Death Dis,2018,9(2):17-19.
[31] NEAULT M,MALLETTE F A,RICHARD S.miR-137 modulates a tumor suppressor network-inducing senescence in pancreatic cancer cells[J].Cell Rep,2016,14(8):1966-1978. |
